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Fibrillarin, a protein component of C/D box small nucleolar ribonucleoproteins (snoRNPs), directs 2-O-
methylation of rRNA and is also involved in other aspects of rRNA processing. A gene trap screen in embryonic
stem (ES) cells resulted in an insertion mutation in the fibrillarin gene. This insertion generated a fusion
protein that contained the N-terminal 132 amino acids of fibrillarin fused to a -galactosidase–neomycin
phosphotransferase reporter. As a result, the N-terminal GAR domain was present in the fusion protein but
the methyltransferase-like domain was missing. The ES cell line with the targeted fibrillarin allele was
transmitted through the mouse germ line, creating heterozygous animals. Western blot analyses showed a
reduction in fibrillarin protein levels in the heterozygous knockout animals. Animals homozygous for the
mutation were inviable, and massive apoptosis was observed in early Fibrillarin/ embryos, showing that
fibrillarin is essential for development. Fibrillarin/ live-born mice displayed no obvious growth defect, but
heterozygous intercrosses revealed a reduced ratio of / to / mice, showing that some of the Fibrillarin
heterozygous embryos die in utero. Analyses of tissue samples and cultured embryonic fibroblasts showed no
discernible alteration in pre-rRNA processing or the level of the U3 snoRNA. However, the level of the
intron-encoded box C/D snoRNA U76 was clearly reduced. This suggests a high requirement for snoRNA
synthesis during an early stage in development.
Stable cellular RNAs, such as tRNAs, rRNAs, and small
nuclear RNAs (snRNAs), contain a large number of posttran-
scriptional modifications. The most prevalent modifications in
rRNAs and spliceosomal snRNAs are the methylation of the
ribose moiety at the 2-hydroxyl group and the conversion of
uridines into pseudouridines, which is directed by guide small
nucleolar RNAs (snoRNAs) (reviewed in 6, 15, and 34).
The small nucleolar RNAs (snoRNAs) play a key role in
several aspects of pre-rRNA processing, including cleavage
and pre-rRNA modification. The snoRNAs are present in the
cell as small nucleolar ribonucleoprotein particles (snoRNPs)
and can be divided into three groups, based on conserved
sequence elements (36). A large family of snoRNAs that share
two short sequence elements, called boxes C and D, serve as
methylation guides; whereas the H/ACA snoRNAs are the
pseudouridylation guide snoRNAs (for a review, see reference
44). The box C/D type snoRNAs have sequences 10 to 22
nucleotides in length of perfect complementarity to sequences
within the mature rRNAs; thus, formation of snoRNA-rRNA
hybrids positions the conserved box D or D element of the
snoRNA five base pairs from the nucleotide to be methylated.
Each snoRNP consists of a specific snoRNA and a set of
associated proteins common to all box C/D or H/ACA
snoRNPs. The box C/D snoRNPs contain four essential pro-
teins, Nop56p, Nop58p, Snu13p, and Nop1p/fibrillarin (17),
and it was shown that binding of the 15.5K protein (Snu13p in
Saccharomyces cerevisiae) to the box C/D motif is required for
the association of the other C/D snoRNP-associated proteins
(43). The distribution of these box C/D-associated proteins is
asymmetric with the C box contacting Nop56 and fibrillarin,
the C box interacting with Nop58, and the D and D boxes
contacting fibrillarin (5).
Human fibrillarin contains an amino-terminal domain that is
rich in glycine and arginine residues (termed the GAR do-
main), a central RNA-binding domain comprising an RNP-2-
like consensus sequence, and a C-terminal -helical domain
(3). Crystal structure of a fibrillarin homolog from archaebac-
teria revealed that the overall fold of its C-terminal domain
was similar to the catalytic domain common to many S-adeno-
sylmethionine-dependent methyltransferases (42). The archae-
bacterial homologs lack the N-terminal GAR domain that is
present in eukaryotes (1). Phylogenetic analysis determined a
high sequence identity in the C-terminal domain among many
fibrillarin homologs, strongly suggesting that they all contain a
methyltransferase folding domain (42).
Fibrillarin has been highly conserved throughout evolution;
for instance, human fibrillarin is 67% identical to its yeast
homolog, termed Nop1p (for nucleolar protein 1) and 81%
identical to the Xenopus protein (3, 10). Antifibrillarin auto-
antibodies are present in patients with the autoimmune disease
scleroderma and are able to detect this protein in different
organisms (19, 23, 24). A fibrillarin knockout is lethal in S.
cerevisiae, and expression of human or Xenopus fibrillarin can
functionally replace NOP1 (13). A series of temperature-sen-
sitive lethal point mutations demonstrated that fibrillarin is
involved in several functions, namely, pre-rRNA processing
and modification and also ribosome assembly (38). Moreover,
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a point mutation in the putative methyltransferase domain of
the yeast fibrillarin, Nop1p, inhibits the overall ribose methyl-
ation of rRNAs (38), suggesting that fibrillarin is the methyl-
transferase in box C/D snoRNPs.
Contrary to snRNAs, which have a cytoplasmic phase of
maturation, snoRNAs are restricted to the nucleus (31, 32).
Nucleolar localization of box C/D snoRNAs requires the box
C/D motif and involves transit through the Cajal bodies (CBs)
(18, 25, 41). The protein components of these snoRNPs are
essential for this localization, since depletion of the core
snoRNP proteins results in failure of box C/D snoRNAs to
accumulate in the nucleolus. Metazoan fibrillarin, which local-
izes to the Cajal bodies and to the nucleoli, has been shown to
interact directly with the spinal muscular atrophy disease pro-
tein SMN, and this interaction is dependent on transcription by
RNA polymerase I (14, 22). Moreover, fibrillarin and SMN
exist as a complex in vivo in HeLa cells and colocalize in both
nucleoli and Cajal bodies. These results suggested a role for
the SMN protein in nucleolar RNA biogenesis (reviewed in
reference 33). Inactivation of the SMN gene results in massive
cell death in early mouse embryos, demonstrating that the
SMN gene product is essential for normal development (26).
The recruitment of the SMN protein to Cajal bodies is medi-
ated by dimethyl arginines present in p80 coilin, a protein that
is a marker for the Cajal bodies (9). A coilin knockout mouse
lacking the C-terminal 487 amino acids of coilin displayed
residual Cajal bodies that failed to recruit SMN and spliceo-
somal Sm snRNP proteins, but did contain fibrillarin (39).
In this study, we analyzed the effect of depleting fibrillarin in
the mouse. A gene trap screen in embryonic stem (ES) cells
rendered an insertion mutation in the fibrillarin gene. This line
was transmitted through the germ line, and live-born heterozy-
gous animals displayed no obvious phenotype; however, we
observed the loss of heterozygous animals. In contrast, ho-
mozygous knockout animals were not viable, demonstrating an
essential role for fibrillarin in normal development.
MATERIALS AND METHODS
Gene targeting. The gene trap screen was performed with pGT1, -2, and -3, as
previously described (29, 30). The ES cell line E14 (12) was maintained in the
presence of leukemia inhibitory factor and electroporated with a mixture of 50
g each of pGT1, -2, and -3 that had been linearized with HindIII (30). Neo-
mycin-resistant E14 colonies were selected with 200 g of geneticin/G418 (Gibco
BRL) per ml for 10 days, and resistant colonies were differentiated in medium
containing 5% fetal calf serum without leukemia inhibitory factor.
Cytological examination of fusion proteins. Neomycin-resistant colonies were
first screened for -galactosidase/lacZ activity with 5-bromo-4-chloro-3-indoyl-
-D-galactoside (X-Gal). Lines that displayed nuclear X-Gal staining were then
analyzed by immunofluorescence with antibodies specific for -galactosidase
(30). Slides were counterstained with 0.5 g of 4,6-diamidino-2-phenylindole
(DAPI) and examined on a Zeiss Axioplan II microscope, and images were
captured with a Princeton Instruments Pentamax charge-coupled device camera
with IPLab software.
Determining the sequence of trapped genes. Total RNA was prepared with
Bio/RNA-X-cell (Bio/Gene Limited), and 5 rapid amplification of cDNA ends
(RACE) products were generated as described previously (29, 30). After dialysis
on 0.1 m nitrocellulose disks (Millipore), 5-RACE products were sequenced
directly with Big Dye terminator cycle sequencing and 40 lacZ primer (USB/
Amersham). Databases were searched for sequence matches with the BLAST
algorithm (http://www.ncbi.nlm.gov/BLAST/).
Mouse breeding and genotyping. Gene trap integrations were transmitted
through the germ line by injection of ES cells into C57BL/6 blastocysts. Chimeric
males were then back crossed to MF1 outbred and C57BL/6 inbred females, and
offspring were analyzed by PCR. Several backcross generations were performed
on the C57BL/6 genetic background prior to setting up heterozygous inter-
crosses. Mouse genomic tail DNA was prepared according to standard proce-
dures. The wild-type fibrillarin allele was detected with primers corresponding to
intron 4 (i4F) and exon 5 (wtR), resulting in the amplification of a 715-bp
fragment. The mutant fibrillarin allele was detected with primers corresponding
to intron 4 (i4F) and the lacZ cassette (mutR), resulting in the amplification of
a 550-bp fragment that diagnoses the targeted allele.
The sequences of the primers were as follows: i4F, GGTTCATATGGTGC
CGTGC; wtR CCACTACTCAGTGCAGTGC; and mutR, GGTTCATATG
GTGCCGTGC. PCR conditions were 5 min at 94°C, followed by two cycles of
94°C for 45 s,70°C for 45 s, and 72°C for 45 s; then two cycles of 94°C for 45 s,
65°C for 45 s, and 72°C for 45 s; followed by two cycles of 94°C for 45 s, 62°C for
45 s, and 72°C for 45 s; then two cycles of 94°C for 45 s, 58°C for 45 s, and 72°C
for 45 s; and finally 25 cycles at 94°C for 45 s, 55°C for 45 s, and 72°C for 45 s and
a final 5-min incubation at 72°C.
Analysis of rRNA and snoRNA processing. Total RNA was extracted from
tissue samples and MEF cells with Total RNA Isolation reagent (Advanced
Biotechnologies Ltd.) following the manufacturer’s instructions. Northern anal-
yses were performed on RNA separated on 1.2% agarose–formaldehyde or 8%
polyacrylamide–urea gels as previously described (35).
Hybridization probes were as follows: (064) mITS2-5 CAA GCG ACG CTC
AGA CA; (065) mITS1-5 TAT TTC GGG TGT GAG CG; (067) m5ETS/18S
AGG TAA GGA AGC GCG AG; (008) 18S CAT GGC TTA ATC TTT GAG
AC; (007) 25S CTCCGCTTATTGATATGC; (034) 5.8S GCT AGC TGC GTT
CTT CAT C; (200) U3A UUA UGG GAC UUG UU (2-O-methyl RNA); (283)
mU76 CAA GAG TAG CAA ATA TGA TG; and (284) mU83 CAG TCA TGG
GTG ATA GAT.
Embryonic expression pattern of fibrillarin. At 9.5 and 12.5 days postcoitus
(dpc), embryos dissected from heterozygous intercrosses were fixed for 30 min in
0.5% glutaraldehyde made up in 0.1 M phosphate buffer (pH 7.3)–2 mM
MgCl2–5 mM EGTA. Embryos were then washed twice at room temperature in
wash buffer (0.1 M phosphate buffer, 2 mM MgCl2, 1% deoxycholate, 2%
Nonidet-P40). The embryos were then incubated with an X-Gal staining solution
overnight at 37°C. The X-Gal staining solution was prepared by mixing 1 ml of
a stock solution of X-Gal (25 mg/ml in dimethyl sulfoxide) with 48 ml of wash
buffer containing 5 mM potassium ferrocyanide and 5 mM potassium ferricya-
nide made up in wash buffer. After staining, the embryos were rinsed with wash
buffer and examined on a Leica M2FL III stereo microscope, and images were
recorded with a Photometrics CoolSnap color camera.
Histology. Freshly isolated tissues from 6-month-old heterozygous mutant
animals and wild-type littermates were fixed overnight in 10% neutral buffered
formalin at 4°C and dehydrated through increasing concentrations of ethanol.
Paraffin-embedded sections were stained with hematoxylin and eosin.
Establishment of MEF lines. At 12.5 dpc, embryos were dissected from het-
erozygous intercross matings, and spleens were removed and disaggregated with
a 20-gauge needle into Dulbecco’s modified Eagle’s medium containing nones-
sential amino acids, penicillin, streptomycin, 15% fetal calf serum, 1% -mer-
captoethanol, and 1% L-glutamate. Cultures were left in a 37°C incubator for 2
to 3 days, when fibroblasts could be seen growing out from the tissue mass. Cells
were trypsinized at this point and left to settle in a 50-ml Falcon tube for 1 to 2
min. Lumps of tissue sedimented, and the cell suspension was replated and
cultured for several passages.
Western blot analysis. Protein extracts were prepared from wild-type and
heterozygous mouse embryonic fibroblast cell lines (MEFs) and mouse NIH 3T3
cells. A 10-cm dish of confluent cells was washed twice with phosphate-buffered
saline (PBS), and then cells were resuspended in 200 l of protein loading dye
and left on ice for 5 min. Extracts were boiled at 100°C for 8 min and sonicated
before storage at 20°C. Proteins were resolved on sodium dodecyl sulfate–10%
polyacrylamide gel electrophoresis (SDS-PAGE) gels and transferred to a Hy-
bond-P membrane for Western analysis by semidry blotting. Membranes were
challenged with 1:1,000 dilutions of either immune serum to fibrillarin (mono-
clonal antibody D77) (2) or to -galactosidase (5-3 Inc). Bound antibody was
visualized with Pierce SuperSignal chemiluminescent substrate by autoradiogra-
phy. Total proteins were identified by Coomassie blue staining to control for
loading differences between samples.
Immunochemical methods and antibodies. The MEF cell lines were washed
with PBS and incubated with 3% paraformaldehyde–0.3% Triton (in PBS) for 5
min at room temperature, followed by incubation with 3% paraformaldehyde for
30 min. The fixed cells were incubated for 1 h at room temperature with 1:1,000
antifibrillarin monoclonal antibody 38F3 (EnCor Biotechnology Inc.), washed
three times with PBS, and incubated for 1 h at room temperature with 1:500
fluorescein-conjugated goat anti-mouse IgG (Cappel Laboratories). Samples
were observed on a Zeiss Axioplan II microscope and images were acquired with
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a Princeton Instruments Pentamax charge-coupled device camera with IPLab
software.
TUNEL staining. Embryos derived from Fibrillarin/ intercrosses were
flushed at day 2.5dpc and cultured overnight. At day 3.5dpc, embryos were
washed with PBS and fixed in 4% paraformaldehyde–PBS for 5 min at room
temperature. They were subsequently washed three times with PBS for 5 min and
permeabilized in 0.1% Triton X-100–0.1% sodium citrate for 2 min on ice.
Following two rinses with PBS, embryos were incubated with terminal deoxynu-
cleotidyl transferase and fluorescein-labeled dUTP for terminal deoxynucleoti-
dyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) (In Situ Cell
Death Detection kit; Boehringer Mannheim) at 37°C for 1 h. Embryos were
subsequently destained three times with PBS for 10 to 15 min before they were
analyzed with a Zeiss Axiovert 100 inverted microscope and photographed with
a Hamamatsu ORCA-ER charge-coupled device camera with IPLab software.
After analysis, the embryos were individually transferred into PCR tubes and
processed for genotyping. A multiplex PCR assay was applied with a common
forward primer and two reverse primers specific for the wild-type and the mu-
tated fibrillarin gene trap locus, as described for Fig. 2. PCR conditions were
identical to those described for Fig. 2.
RESULTS AND DISCUSSION
Generation of the mutation. A gene trap screen in mouse
embryonic stem cells identified an insertion mutation in the
fibrillarin gene. In brief, a -galactosidase–neomycin phospho-
transferase (geo) reporter gene, lacking its own promoter and
ATG, can be spliced in frame into the gene transcript when
integrated into an intron of an expressed gene (Fig. 1A) (30).
The sequence of the trapped gene is identified by 5 RACE
from the fusion transcript. This cell line, termed ES 403, was
previously reported as part of a gene trap screen (29). The
insertion event occurred in intron 4 of the fibrillarin gene and
resulted in a fusion protein that contained the N-terminal 132
amino acids of fibrillarin fused to the geo reporter. As a result
of this, only the N-terminal GAR domain and the spacer 1
region are present in the fusion protein, but the RNP domain
and the -helical domain are missing (Fig. 1B). More impor-
tantly, the missing region in the fusion protein comprises the
methyltransferase-like domain (Fig. 1B). Whereas endogenous
wild-type fibrillarin localized to the nucleoli and to Cajal bod-
ies, the trapped fibrillarin protein in ES cells localized to the
nucleoli and also showed a diffuse nuclear localization; how-
ever, no localization to the Cajal bodies was observed (data not
shown). This is most likely due to the missing sequences in the
geo-fibrillarin fusion protein. Interestingly, a fibrillarin-green
fluorescent protein (GFP) fusion construct comprising the
GAR domain and spacer 1 (which resembles exactly the fibril-
larin domains present in the fusion protein) also localized to
the nucleoplasm and to the nucleoli, but failed to localize to
the Cajal bodies (see Fig. 2 in reference 27).
Gene trap events are mutagenic; hence, each ES cell line is
heterozygous for what is most likely to be a loss-of-function
mutation of the gene in question. The phenotype of heterozy-
gous and homozygous mutations resulting from the fibrillarin
gene trap event was investigated in the mouse through the
generation of chimeras from a trapped ES cell line (ES 403)
and then transmission through the germ line from these ani-
mals. Three independent lines of heterozygous mice were gen-
erated following blastocyst injection. Genotyping of heterozy-
gous intercross progeny was done by PCR analysis of blastocyst
stage embryos and of adult mice. The wild-type allele was
amplified with primers corresponding to intron 4 and exon 5 of
fibrillarin, resulting in an amplified product of 715 bp, which is
not amplified in the targeted allele due to the insertion of
approximately 3 kb of the lacZ cassette (Fig. 2). In contrast, a
550-bp band, amplified with the intron 4 forward primer and a
reverse primer in the lacZ cassette, is diagnostic of the mutant
fibrillarin allele (Fig. 2). Intercrosses of heterozygotes from
each line failed to produce homozygous Fibrillarin/ adult
progeny, demonstrating that fibrillarin is an essential protein
for development (Fig. 3). Analysis of embryos from heterozy-
gous intercrosses also failed to show any Fibrillarin/ prog-
eny, even as early as 7.5 dpc (Table 1). The / sample shown
in Fig. 2 corresponds to an early embryo (2.5 dpc) generated
from a heterozygous intercross, since, as described above, no
adult / progeny was ever detected (Fig. 3 and Table 1, and
also see Fig. 7, below).
Fibrillarin heterozygous mutant mice. We did not observe
any discernible phenotype in Fibrillarin/ live-born mice, de-
spite the fact that a large decrease in the levels of fibrillarin
protein was observed in cell lines derived from / mice (see
FIG. 1. Disruption of the murine Fibrillarin gene. (A) Gene trap
screening (29, 30). (B) Amino acid sequence of mouse wild-type and
trapped fibrillarin proteins (top), and a cartoon depicting the domains
present in both proteins (below).
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below, Fig. 6). This would suggest that an approximate 50%
decrease in fibrillarin protein levels is well tolerated.
However, we found that Fibrillarin/ and Fibrillarin/
mice did not segregate in the expected 2:1 ratio; thus, a signif-
icant proportion of heterozygous embryos must die during
early development (Fig. 3). Thus, it is likely that the level of
fibrillarin protein becomes limiting at an early stage of devel-
opment. Interestingly, there was an indication of increased
uterine reasorption starting at 9.5dpc, suggesting that Fibrilla-
rin/ and some Fibrillarin/ embryos may implant but do not
complete embryogenesis (Table 1).
It is notable that analysis of mice deficient for p80/coilin
showed an underrepresentation of / mice relative to /
and / animals (39), even though the surviving / mice
showed apparently normal growth. Coilin is a component of
the Cajal bodies, in which snoRNP maturation occurs (re-
viewed in references 7 and 16), and these observations may
indicate a particularly sensitive requirement for snoRNP as-
sembly at an early stage in development.FIG. 2. Fibrillarin knockout mice. Genotyping of heterozygous in-
tercross progeny by PCR analysis. The wild-type allele was identified
with primers corresponding to intron 4 and exon 5 of fibrillarin, re-
sulting in an amplified product of 715 bp. These two primers are on
either side of the gene trap integration site; thus, the mutant allele is
interrupted by 3 kb of the lacZ cassette. This results in a lack of
amplification and the absence of this PCR product in the targeted
allele. The fibrillarin mutant allele was identified with primers corre-
sponding to sequences in intron 4 and a reverse primer in the lacZ
construct, giving rise to a 550-bp band, which is not produced in the
wild-type allele.
FIG. 3. Fibrillarin heterozygous intercross progeny, showing the
distribution of/,/, and/mice. Intercrosses of heterozygotes
from each line failed to produce homozygous Fibrillarin/ progeny,
and in addition, a significant number of heterozygous mice were lost.
FIG. 4. Northern analyses of rRNA and snoRNA processing
in MEFs derived from Fibrillarin/ mice. RNA was separated on a
1.2% agarose–/formaldehyde gel to analyze high-molecular-weight
pre-rRNAs and rRNAs (panel A) or 8% polyacrylamide–urea gels to
analyze low-molecular-weight pre-rRNAs and rRNA (panel B) and
snoRNAs (panel C). RNA species identified are indicated on the right
of each panel.
TABLE 1. PCR analysis of Fibrillarin embryos from heterozygous
intercrosses
dpc
No. of progeny No. of
reabsorption sites/ / /
7.5 4 11 0 0
8.5 6 12 0 0
9.5 6 6 0 13
10.5 5 5 0 15
11.5 4 10 0 5
12.5 5 12 0 16
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FIG. 5. (A) Analysis of fibrillarin expression in Fibrillarin/ embryos. Heterozygous males were mated to heterozygous females to determine
fibrillarin gene expression during mouse development. Fibrillarin expression, as measured by -galactosidase activity, is ubiquitous until 11.5 dpc,
when the expression pattern became more restricted to highly proliferating tissues such as neural tube and limb buds. (B) Hematoxylin- and
eosin-stained wax sections of testis, skin, liver, and intestine from wild-type (/) and heterozygous mutant (/) mice. Magnification, 20.
VOL. 23, 2003 FIBRILLARIN MUTANT MICE 8523
rRNA processing is not affected in Fibrillarin/ cell lines
and/or tissues. RNA processing was analyzed in brain and liver
tissue samples (data not shown), and in mouse embryonic
fibroblasts (MEFs) derived from / and / mice (Fig. 4A
and B). In Saccharomyces cerevisiae, fibrillarin is required for
several steps in pre-rRNA processing and subunit assembly
(reviewed in reference 40), and the independently transcribed,
fibrillarin-associated box C/D snoRNAs U3 (4), U8 (21), and
U22 (20) are required for pre-rRNA processing in Xenopus
oocytes. However, no clear differences were observed in the
levels of any pre-rRNA species, and no alterations were de-
tected in the accumulation of the mature rRNAs in / rel-
ative to / mice in either the tissue samples or the MEFs.
For further description of the pre-rRNA species and process-
ing pathway, see Strezoska et al. (28).
An intron-encoded snoRNA is codepleted with fibrillarin.
Yeast Nop1p is dispensable for accumulation of independently
transcribed box C/D snoRNAs, including U3, but is required
for the maturation and accumulation of intron-encoded box
C/D snoRNAs (17, 37). In the case of U18 at least, snoRNA
release from the host intron requires the interaction of Nop1p
with the Rnt1p endonuclease (8). In mouse cells, fibrillarin
binds to intronic pre-snoRNAs prior to processing (11), sug-
gesting a general role for fibrillarin in snoRNA processing
(reviewed in reference 36). The independently transcribed U3
and intron-encoded U76 box C/D snoRNAs were analyzed
FIG. 6. (A) Western blots showing reduced fibrillarin protein expression in mouse embryonic fibroblasts derived from Fibrillarin/ mice. The
left panel shows the endogenous fibrillarin protein detected with a specific antibody. The middle panel shows the fibrillarin-geo fusion protein
detected with an anti--galactosidase antibody. The right panel shows total proteins detected by Coomassie blue staining. (B) Localization of
fibrillarin-geo fusion protein and of endogenous fibrillarin in mouse embryonic fibroblasts derived from / and / mice with antibodies
specific to -galactosidase and fibrillarin, respectively.
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(shown in Fig. 4C; note that all panels in Fig. 4C show hybrid-
ization of the same filter, allowing their direct comparison).
The level of the U3 snoRNA was not clearly altered in either
the tissue sample or MEFs, whereas the level of U76 was
markedly reduced. PhosphorImager quantitation standardized
to the 5.8S rRNA showed that U76 was reduced 1.9-fold in
/ MEF cells relative to the / control. Together, these
results show that a decrease in fibrillarin protein levels results
in a corresponding reduction in the level of an intron-encoded
snoRNA but has little effect on the independently transcribed
U3 snoRNA or rRNA accumulation.
Analysis of fibrillarin expression in mutant animals. The
pattern of fibrillarin gene expression during development was
analyzed in whole-mount 9.5- and 11.5-dpc heterozygous em-
bryos. Fibrillarin expression, as measured by -galactosidase
activity, was ubiquitous at 9.5 dpc, but the expression pattern
became more restricted to highly proliferating tissues such as
neural tube and limb buds at 11.5 dpc (Fig. 5A). The pattern of
fibrillarin gene expression was also analyzed in tissue sections
of / mutant mice. We observed that fibrillarin was highly
expressed in the ovary of adult / mice (data not shown).
This would indicate that the fibrillarin protein is made in oo-
cytes of mothers with an intact gene copy and may be trans-
ferred to and used by early embryonic cells during the first
rounds of division. The persistence of maternally produced
protein in the embryo could explain the normal development
of fibrillarin-depleted embryos to the early morula stage de-
spite deletion of the Fibrillarin gene in the embryo (see Fig. 7).
Fibrillarin expression was also high in testis and liver, which
are both highly proliferating tissues, as expected from a protein
involved in ribosome biogenesis (data not shown).
Histological analysis was performed on tissues isolated from
adult wild-type and heterozygous mutant mice, and no discern-
ible differences were observed in highly proliferating tissues
such as, testis, skin, liver, and intestine (Fig. 5B).
Fibrillarin expression in wild-type and heterozygote-derived
MEFs. Western blot analysis of embyronic protein with an
antifibrillarin antibody confirmed that there was a large de-
crease in fibrillarin protein levels in mouse embryonic fibro-
blasts derived from 12.5-dpc / embryos compared to MEFs
derived from wild-type embryos (Fig. 6A, left panel). As ex-
pected, the -galactosidase antibody revealed the presence of
a fusion protein only in MEFs derived from heterozygous
embryos (Fig. 6A, middle panel).
We analyzed the subcellular distribution of endogenous
fibrillarin and of the fibrillarin-geo fusion protein in mouse
embryonic fibroblasts derived from fibrillarin / and /
mice with antibodies specific for fibrillarin and -galactosidase,
respectively. As observed in ES cells (data not shown), endog-
enous wild-type fibrillarin localizes primarily to nucleoli in
MEF cell lines, whereas the trapped fibrillarin fusion protein
localized to the nucleoli but also showed a diffuse nuclear
localization (Fig. 6B). We also found that the subcellular lo-
calization of other nuclear proteins that localize to the Cajal
bodies or to the nucleolus, such as SMN, UBF, nucleolin, and
the spliceosomal Sm proteins, was not altered in heterozygous
MEFs (data not shown).
Massive cell death in early Fibrillarin/ embryos. Progeny
from heterozygous intercrosses were isolated as uncompacted
five to seven-cell morulae 56 h post coitum. The embryos were
maintained overnight in culture and subsequently genotyped
by PCR, as described for Fig. 2. During this time period,
normal morulae first compact (8- to 16-cell stage), then differ-
entiate to cavitating blastocysts (64 cells), and finally expand to
form an inner cell mass and the outer trophoblast cell layer
(128 cells). Homozygous mutant embryos initially were indis-
tinguishable from wild-type and heterozygous embryos. How-
FIG. 7. Homozygous embryos die at 2.5 to 3.5 dpc. Morphological
alterations and TUNEL staining in control and Fibrillarin mutant em-
bryos. A failure in transition to the blastocyst stage first became ap-
parent at 60 h after mating, with subsequent formation of a disorga-
nized, multicystic structure and finally extensive cellular degeneration
at 84 h post coitum. TUNEL staining of Fibrillarin/ embryos showed
strong staining of most cells (f), suggesting apoptotic cell death. In
contrast, wild-type and / blastocysts (b and d, respectively) showed
very few labeled cells.
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ever, after overnight culture these mutant embryos showed
signs of aberrant development; for instance, morulae failed to
compact or form expanded blastocysts in all mutant embryos
(morula arrest) (Fig. 7). At later time points the / embryos
became progressively more disorganized and fragmented with
extensive cellular degeneration.
TUNEL staining of such embryos revealed a high number of
intensely labeled cells, which is diagnostic of apoptotic cell
death (Fig. 7, upper panel [f]). In contrast, heterozygous and
wild-type blastocysts revealed very few apoptotic cells (Fig. 7,
upper panel [b and d]). Abnormal cleavage stage embryos with
degenerating cells are commonly found in laboratory mice,
particularly following superovulation. However, a significant
difference was found in the number of abnormal cleavage stage
embryos between homozygous mutant and heterozygous/wild-
type embryos [X2  18.92; P 	 0.00001]. This indicates that
embryonic lethality at premorula stages is specifically associ-
ated with the loss of the fibrillarin gene. The association of the
morula arrest phenotype with a homozygous mutant genotype
was highly significant (P 	 0.01; /: 1; /: 1; /: 0).
These experiments confirmed that homozygous disruption
of fibrillarin in the mouse leads to developmental arrest and
death prior to implantation. Thus, the death of mutant em-
bryos may coincide with depletion of maternal fibrillarin in
these embryos. In summary, we have shown that homozygous
depletion of mouse fibrillarin leads to embryonic lethality,
which occurs at an early stage of development, and that a
significant proportion of / embryos die during early devel-
opment. These results demonstrate that fibrillarin is essential
for development.
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